Health Response-Based Ponatinib Dose Reduction a Win-Win in Chronic-Phase CML? Eli Pacheco Sep 30, 2022 0 For patients with chronic-phase chronic myeloid leukemia (CML), a response-based dose-reduction strategy for ponatinib (Iclusig)…
Health Can Dasatinib Dose Be Halved in Low-Risk CML? Eli Pacheco Dec 15, 2021 0 ATLANTA -- Using a lower dose of dasatinib (Sprycel) for the initial treatment of chronic myeloid leukemia (CML) in chronic phase…